Taiwan FDA registration b6f18c95aa2086c07cbb0dbc8a301130
Direct method of high-density cholesterol in biological systems
TW: 生物系統高密度膽固醇直接法
Taiwan·Risk Class 1·BIOSYSTEMS S.A.·Registered Aug 31, 2006 – Aug 31, 2011CancelledRegistration details
- Analysis ID
- b6f18c95aa2086c07cbb0dbc8a301130
- Customs Code
- DHA04400510802
Company information
- Manufacturer
- BIOSYSTEMS S.A.
- Manufacturer Country
- Spain
- Authorized Representative
- BIOMED INSTRUMENTS CO., LTD.
Product details
- Intended Use
- Limited to the first level recognition range of the lipoprotein test system (A.1475) of the medical device management method.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1475 Lipoprotein Testing System
- Import Information
- import
Dates and status
- Registration Date
- Aug 31, 2006
- Expiry Date
- Aug 31, 2011
- Cancellation Date
- Jan 18, 2013
Cancellation information
- Status
- Logged out
- Reason
- 許可證已逾有效期
About this record
Access comprehensive regulatory information for Direct method of high-density cholesterol in biological systems in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number b6f18c95aa2086c07cbb0dbc8a301130 and manufactured by BIOSYSTEMS S.A.. The authorized representative in Taiwan is BIOMED INSTRUMENTS CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices